Pediatric Lupus-Are There Differences in Presentation, Genetics, Response to Therapy, and Damage Accrual Compared with Adult Lupus?

Rheumatic Disease Clinics of North America

Volumn 36, Issue 1, 2010, Pages 53-80

  Mina, Rina ^a   Brunner, Hermine I ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Adults; Children; Complement; Lupus; Lupus nephritis; Pediatric SLE

Indexed keywords

ANTIMALARIAL AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAPSONE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; VINCRISTINE;

ADULT; ANTIPHOSPHOLIPID SYNDROME; CHILD; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE COURSE; DRUG EFFICACY; DRUG MEGADOSE; ENDOCRINE DISEASE; GASTROINTESTINAL DISEASE; GENETIC DISORDER; GENETICS; HEALTH CARE COST; HEART DISEASE; HEMATOLOGIC DISEASE; HUMAN; IMMUNOPATHOLOGY; LUNG DISEASE; LUPUS ERYTHEMATOSUS NEPHRITIS; MENTAL DISEASE; MUSCULOSKELETAL DISEASE; NEUROLOGIC DISEASE; PRESCRIPTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SEX RATIO; SJOEGREN SYNDROME; SURVIVAL; SYSTEMIC LUPUS ERYTHEMATOSUS; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADULT; AGE FACTORS; ANEMIA; ANTI-INFLAMMATORY AGENTS; CHILD; COMPLEMENT SYSTEM PROTEINS; DISEASE PROGRESSION; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; SEX FACTORS; SURVIVAL ANALYSIS;

EID: 77349089975     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2009.12.012     Document Type: Review

References (166)

1. Brunner H.I., Gladman D.D., Ibanez D., et al. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Rheum 58 2 (2008) 556-562
2. Font J., Cervera R., Espinosa G., et al. Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults. Ann Rheum Dis 57 8 (1998) 456-459
3. Hersh A.O., von Scheven E., Yazdany J., et al. Differences in long-term disease activity and treatment of adult patients with childhood- and adult-onset systemic lupus erythematosus. Arthritis Rheum 61 1 (2009) 13-20
4. Hoffman I.E., Lauwerys B.R., De Keyser F., et al. Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus. Ann Rheum Dis 68 3 (2009) 412-415
5. Rood M.J., ten Cate R., van Suijlekom-Smit L.W., et al. Childhood-onset Systemic Lupus Erythematosus: clinical presentation and prognosis in 31 patients. Scand J Rheumatol 28 4 (1999) 222-226
6. Tucker L.B. Making the diagnosis of systemic lupus erythematosus in children and adolescents. Lupus 16 8 (2007) 546-549
7. Tucker L.B., Menon S., Schaller J.G., et al. Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Br J Rheumatol 34 9 (1995) 866-872
8. Tucker L.B., Uribe A.G., Fernandez M., et al. Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII). Lupus 17 4 (2008) 314-322
9. Pluchinotta F.R., Schiavo B., Vittadello F., et al. Distinctive clinical features of pediatric systemic lupus erythematosus in three different age classes. Lupus 16 8 (2007) 550-555
10. Danchenko N., Satia J.A., and Anthony M.S. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus 15 5 (2006) 308-318
11. Malleson P.N., Fung M.Y., and Rosenberg A.M. The incidence of pediatric rheumatic diseases: results from the Canadian Pediatric Rheumatology Association Disease Registry. J Rheumatol 23 11 (1996) 1981-1987
12. Nossent H.C. Systemic lupus erythematosus in the Arctic region of Norway. J Rheumatol 28 3 (2001) 539-546
13. McCarty D.J., Manzi S., Medsger Jr. T.A., et al. Incidence of systemic lupus erythematosus. Race and gender differences. Arthritis Rheum 38 9 (1995) 1260-1270
14. Tucker L.B., Uribe A.G., and Fernandez M. Clinical differences between juvenile and adult onset patients with systemic lupus erythematosus: results from a multiethnic longitudinal cohort. Arthritis Rheum 54 6 (2006) S162
15. Costallat L.T., and Coimbra A.M. Systemic lupus erythematosus: clinical and laboratory aspects related to age at disease onset. Clin Exp Rheumatol 12 6 (1994) 603-607
16. Hiraki L.T., Benseler S.M., Tyrrell P.N., et al. Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study. J Pediatr 152 4 (2008) 550-556
17. Carreno L., Lopez-Longo F.J., Monteagudo I., et al. Immunological and clinical differences between juvenile and adult onset of systemic lupus erythematosus. Lupus 8 4 (1999) 287-292
18. Descloux E., Durieu I., Cochat P., et al. Paediatric systemic lupus erythematosus: prognostic impact of antiphospholipid antibodies. Rheumatology (Oxford) 47 2 (2008) 183-187
19. Bader-Meunier B., Armengaud J.B., Haddad E., et al. Initial presentation of childhood-onset systemic lupus erythematosus: a French multicenter study. J Pediatr 146 5 (2005) 648-653
20. Iqbal S., Sher M.R., Good R.A., et al. Diversity in presenting manifestations of systemic lupus erythematosus in children. J Pediatr 135 4 (1999) 500-505
21. Hiraki L., Benseler S., Tyrrell P., et al. Ethnic differences in pediatric systemic lupus erythematosus. J Rheumatol 36 11 (2009) 2539-2546
22. Cooper G.S., Parks C.G., Treadwell E.L., et al. Differences by race, sex and age in the clinical and immunologic features of recently diagnosed systemic lupus erythematosus patients in the southeastern United States. Lupus 11 3 (2002) 161-167
23. Gattorno M., Buoncompagni A., Molinari A.C., et al. Antiphospholipid antibodies in paediatric systemic lupus erythematosus, juvenile chronic arthritis and overlap syndromes: SLE patients with both lupus anticoagulant and high-titre anticardiolipin antibodies are at risk for clinical manifestations related to the antiphospholipid syndrome. Br J Rheumatol 34 9 (1995) 873-881
24. Ramirez Gomez L.A., Uribe Uribe O., Osio Uribe O., et al. Childhood systemic lupus erythematosus in Latin America. The GLADEL experience in 230 children. Lupus 17 6 (2008) 596-604
25. Meislin A.G., and Rothfield N. Systemic lupus erythematosus in childhood. Analysis of 42 cases, with comparative data on 200 adult cases followed concurrently. Pediatrics 42 1 (1968) 37-49
26. Del Boz J., Martin T., Samaniego E., et al. Childhood discoid lupus in identical twins. Pediatr Dermatol 25 6 (2008) 648-649
27. Sampaio M.C., de Oliveira Z.N., Machado M.C., et al. Discoid lupus erythematosus in children-a retrospective study of 34 patients. Pediatr Dermatol 25 2 (2008) 163-167
28. Santiago M.B., and Galvao V. Jaccoud arthropathy in systemic lupus erythematosus: analysis of clinical characteristics and review of the literature. Medicine (Baltimore) 87 1 (2008) 37-44
29. Nord J.E., Shah P.K., Rinaldi R.Z., et al. Hydroxychloroquine cardiotoxicity in systemic lupus erythematosus: a report of 2 cases and review of the literature. Semin Arthritis Rheum 33 5 (2004) 336-351
30. Kanayama Y., Shiota K., Horiguchi T., et al. Correlation between steroid myopathy and serum lactic dehydrogenase in systemic lupus erythematosus. Arch Intern Med 141 9 (1981) 1176-1179
31. Alsufyani K.A., Ortiz-Alvarez O., Cabral D.A., et al. Bone mineral density in children and adolescents with systemic lupus erythematosus, juvenile dermatomyositis, and systemic vasculitis: relationship to disease duration, cumulative corticosteroid dose, calcium intake, and exercise. J Rheumatol 32 4 (2005) 729-733
32. Trapani S., Civinini R., Ermini M., et al. Osteoporosis in juvenile systemic lupus erythematosus: a longitudinal study on the effect of steroids on bone mineral density. Rheumatol Int 18 2 (1998) 45-49
33. Cervera R., Khamashta M.A., Font J., et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 82 5 (2003) 299-308
34. Pineau C.A., Urowitz M.B., Fortin P.J., et al. Osteoporosis in systemic lupus erythematosus: factors associated with referral for bone mineral density studies, prevalence of osteoporosis and factors associated with reduced bone density. Lupus 13 6 (2004) 436-441
35. Yeap S.S., Fauzi A.R., Kong N.C., et al. A comparison of calcium, calcitriol, and alendronate in corticosteroid-treated premenopausal patients with systemic lupus erythematosus. J Rheumatol 35 12 (2008) 2344-2347
36. Wright T.B., Leonard M.B., Zemel B.S., et al. Hypovitaminosis D is associated with greater body mass index and disease activity in pediatric systemic lupus erythematosus. J Pediatr 155 2 (2009) 260-265
37. Zappitelli M., Duffy C.M., Bernard C., et al. Evaluation of activity, chronicity and tubulointerstitial indices for childhood lupus nephritis. Pediatr Nephrol 23 1 (2008) 83-91
38. Marks S.D., Sebire N.J., Pilkington C., et al. Clinicopathological correlations of paediatric lupus nephritis. Pediatr Nephrol 22 1 (2007) 77-83
39. Brunner H.I., Silverman E.D., To T., et al. Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage. Arthritis Rheum 46 2 (2002) 436-444
40. Perfumo F., and Martini A. Lupus nephritis in children. Lupus 14 1 (2005) 83-88
41. Steinlin M.I., Blaser S.I., Gilday D.L., et al. Neurologic manifestations of pediatric systemic lupus erythematosus. Pediatr Neurol 13 3 (1995) 191-197
42. Turkel S.B., Miller J.H., and Reiff A. Case series: neuropsychiatric symptoms with pediatric systemic lupus erythematosus. J Am Acad Child Adolesc Psychiatry 40 4 (2001) 482-485
43. Benseler S.M., and Silverman E.D. Neuropsychiatric involvement in pediatric systemic lupus erythematosus. Lupus 16 8 (2007) 564-571
44. Olfat M.O., Al-Mayouf S.M., and Muzaffer M.A. Pattern of neuropsychiatric manifestations and outcome in juvenile systemic lupus erythematosus. Clin Rheumatol 23 5 (2004) 395-399
45. Sibbitt Jr. W.L., Brandt J.R., Johnson C.R., et al. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus. J Rheumatol 29 7 (2002) 1536-1542
46. Hanly J.G., Urowitz M.B., Su L., et al. Short-term outcome of neuropsychiatric events in systemic lupus erythematosus upon enrollment into an international inception cohort study. Arthritis Rheum 59 5 (2008) 721-729
47. Muscal E., and Myones B.L. The role of autoantibodies in pediatric neuropsychiatric systemic lupus erythematosus. Autoimmun Rev 6 4 (2007) 215-217
48. Rivest C., Lew R.A., Welsing P.M., et al. Association between clinical factors, socioeconomic status, and organ damage in recent onset systemic lupus erythematosus. J Rheumatol 27 3 (2000) 680-684
49. Reiff A., Miller J., Shaham B., et al. Childhood central nervous system lupus; longitudinal assessment using single photon emission computed tomography. J Rheumatol 24 12 (1997) 2461-2465
50. Parikh S., Swaiman K.F., and Kim Y. Neurologic characteristics of childhood lupus erythematosus. Pediatr Neurol 13 3 (1995) 198-201
51. Avcin T., Benseler S.M., Tyrrell P.N., et al. A followup study of antiphospholipid antibodies and associated neuropsychiatric manifestations in 137 children with systemic lupus erythematosus. Arthritis Rheum 59 2 (2008) 206-213
52. Harel L., Sandborg C., Lee T., et al. Neuropsychiatric manifestations in pediatric systemic lupus erythematosus and association with antiphospholipid antibodies. J Rheumatol 33 9 (2006) 1873-1877
53. Mikdashi J.A., Alarcón G.S., Crofford L., et al. Proposed response criteria for neurocognitive impairment in systemic lupus erythematosus clinical trials. Lupus 16 (2007) 418-425
54. Brunner H., Levy D., Schanberg L., et al. Standardizing the neuropsychological evaluation of children with systemic lupus erythematosus. 7th European Lupus Congress, Amsterdam. Lupus 17 32 (2008) 467
55. Doherty N.E., and Siegel R.J. Cardiovascular manifestations of systemic lupus erythematosus. Am Heart J 110 6 (1985) 1257-1265
56. Miller D.J., Maisch S.A., Perez M.D., et al. Fatal myocardial infarction in an 8-year-old girl with systemic lupus erythematosus, Raynaud's phenomenon, and secondary antiphospholipid antibody syndrome. J Rheumatol 22 4 (1995) 768-773
57. Asanuma Y., Oeser A., Shintani A.K., et al. Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N Engl J Med 349 25 (2003) 2407-2415
58. Manzi S., Meilahn E.N., Rairie J.E., et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study. Am J Epidemiol 145 5 (1997) 408-415
59. Al-Abbad A.J., Cabral D.A., Sanatani S., et al. Echocardiography and pulmonary function testing in childhood onset systemic lupus erythematosus. Lupus 10 1 (2001) 32-37
60. Swigris J.J., Fischer A., Gillis J., et al. Pulmonary and thrombotic manifestations of systemic lupus erythematosus. Chest 133 1 (2008) 271-280
61. Memet B., and Ginzler E.M. Pulmonary manifestations of systemic lupus erythematosus. Semin Respir Crit Care Med 28 4 (2007) 441-450
62. Murin S., Wiedemann H.P., and Matthay R.A. Pulmonary manifestations of systemic lupus erythematosus. Clin Chest Med 19 4 (1998) 641-665 viii
63. Ferguson P.J., and Weinberger M. Shrinking lung syndrome in a 14-year-old boy with systemic lupus erythematosus. Pediatr Pulmonol 41 2 (2006) 194-197
64. Karim M.Y., Miranda L.C., Tench C.M., et al. Presentation and prognosis of the shrinking lung syndrome in systemic lupus erythematosus. Semin Arthritis Rheum 31 5 (2002) 289-298
65. Samad A.S., and Lindsley C.B. Treatment of pulmonary hemorrhage in childhood systemic lupus erythematosus with mycophenolate mofetil. Southampt Med J 96 7 (2003) 705-707
66. Byun J.Y., Ha H.K., Yu S.Y., et al. CT features of systemic lupus erythematosus in patients with acute abdominal pain: emphasis on ischemic bowel disease. Radiology 211 1 (1999) 203-209
67. Lee C.K., Ahn M.S., Lee E.Y., et al. Acute abdominal pain in systemic lupus erythematosus: focus on lupus enteritis (gastrointestinal vasculitis). Ann Rheum Dis 61 6 (2002) 547-550
68. Richer O., Ulinski T., Lemelle I., et al. Abdominal manifestations in childhood-onset systemic lupus erythematosus. Ann Rheum Dis 66 2 (2007) 174-178
69. Yu H.H., Wang L.C., Lee J.H., et al. Lymphopenia is associated with neuropsychiatric manifestations and disease activity in paediatric systemic lupus erythematosus patients. Rheumatology (Oxford) 46 9 (2007) 1492-1494
70. Martinez-Banos D., Crispin J.C., Lazo-Langner A., et al. Moderate and severe neutropenia in patients with systemic lupus erythematosus. Rheumatology (Oxford) 45 8 (2006) 994-998
71. Schmugge M., Revel-Vilk S., Hiraki L., et al. Thrombocytopenia and thromboembolism in pediatric systemic lupus erythematosus. J Pediatr 143 5 (2003) 666-669
72. Pamuk G.E., Pamuk O.N., Baslar Z., et al. Overview of 321 patients with idiopathic thrombocytopenic purpura. Retrospective analysis of the clinical features and response to therapy. Ann Hematol 81 8 (2002) 436-440
73. Altintas A., Ozel A., Okur N., et al. Prevalence and clinical significance of elevated antinuclear antibody test in children and adult patients with idiopathic thrombocytopenic purpura. J Thromb Thrombolysis 24 2 (2007) 163-168
74. Brunner H.I., Freedman M., and Silverman E.D. Close relationship between systemic lupus erythematosus and thrombotic thrombocytopenic purpura in childhood. Arthritis Rheum 42 11 (1999) 2346-2355
75. Wu C.Y., Su Y.T., Wang J.S., et al. Childhood hermolytic uremic syndrome associated with systemic lupus erythematosus. Lupus 16 12 (2007) 1006-1010
76. Musio F., Bohen E.M., Yuan C.M., et al. Review of thrombotic thrombocytopenic purpura in the setting of systemic lupus erythematosus. Semin Arthritis Rheum 28 1 (1998) 1-19
77. Risdall R.J., McKenna R.W., Nesbit M.E., et al. Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer 44 3 (1979) 993-1002
78. Wong K.F., Hui P.K., Chan J.K., et al. The acute lupus hemophagocytic syndrome. Ann Intern Med 114 5 (1991) 387-390
79. Oka Y., Kameoka J., Hirabayashi Y., et al. Reversible bone marrow dysplasia in patients with systemic lupus erythematosus. Intern Med 47 8 (2008) 737-742
80. Kaiser R., Cleveland C.M., and Criswell L.A. Risk and protective factors for thrombosis in systemic lupus erythematosus: results from a large, multi-ethnic cohort. Ann Rheum Dis 68 2 (2009) 238-241
81. Berube C., Mitchell L., Silverman E., et al. The relationship of antiphospholipid antibodies to thromboembolic events in pediatric patients with systemic lupus erythematosus: a cross-sectional study. Pediatr Res 44 3 (1998) 351-356
82. Iwata N., Mori M., Miyamae T., et al. [Sjogren's syndrome associated with childhood-onset systemic lupus erythematosus]. Nihon Rinsho Meneki Gakkai Kaishi 31 3 (2008) 166-171 [in Japanese]
83. Ostuni P.A., Ianniello A., Sfriso P., et al. Juvenile onset of primary Sjogren's syndrome: report of 10 cases. Clin Exp Rheumatol 14 6 (1996) 689-693
84. Stiller M., Golder W., Doring E., et al. Primary and secondary Sjogren's syndrome in children-a comparative study. Clin Oral Investig 4 3 (2000) 176-182
85. Chikanza I.C., Kuis W., and Heijnen C.J. The influence of the hormonal system on pediatric rheumatic diseases. Rheum Dis Clin North Am 26 4 (2000) 911-925
86. Ilowite N.T., Samuel P., Ginzler E., et al. Dyslipoproteinemia in pediatric systemic lupus erythematosus. Arthritis Rheum 31 7 (1988) 859-863
87. Soep J.B., Mietus-Snyder M., Malloy M.J., et al. Assessment of atherosclerotic risk factors and endothelial function in children and young adults with pediatric-onset systemic lupus erythematosus. Arthritis Rheum 51 3 (2004) 451-457
88. Compeyrot-Lacassagne S., Tyrrell P.N., Atenafu E., et al. Prevalence and etiology of low bone mineral density in juvenile systemic lupus erythematosus. Arthritis Rheum 56 6 (2007) 1966-1973
89. Hua X., Su J., Svenungsson E., et al. Dyslipidaemia and lipoprotein pattern in systemic lupus erythematosus (SLE) and SLE-related cardiovascular disease. Scand J Rheumatol 38 3 (2009) 184-189
90. Tyrrell P.N., Beyene J., Benseler S.M., et al. Predictors of lipid abnormalities in children with new-onset systemic lupus erythematosus. J Rheumatol 34 10 (2007) 2112-2119
91. El Magadmi M., Ahmad Y., Turkie W., et al. Hyperinsulinemia, insulin resistance, and circulating oxidized low density lipoprotein in women with systemic lupus erythematosus. J Rheumatol 33 1 (2006) 50-56
92. Chung C.P., Avalos I., Oeser A., et al. High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors. Ann Rheum Dis 66 2 (2007) 208-214
93. Appenzeller S., Pallone A.T., Natalin R.A., et al. Prevalence of thyroid dysfunction in systemic lupus erythematosus. J Clin Rheumatol 15 3 (2009) 117-119
94. Eberhard B.A., Laxer R.M., Eddy A.A., et al. Presence of thyroid abnormalities in children with systemic lupus erythematosus. J Pediatr 119 2 (1991) 277-279
95. Athreya B.H., Rafferty J.H., Sehgal G.S., et al. Adenohypophyseal and sex hormones in pediatric rheumatic diseases. J Rheumatol 20 4 (1993) 725-730
96. Ronchezel M.V., Len C.A., Spinola e Castro A., et al. Thyroid function and serum prolactin levels in patients with juvenile systemic lupus erythematosus. J Pediatr Endocrinol Metab 14 2 (2001) 165-169
97. Koller M.D., Templ E., Riedl M., et al. Pituitary function in patients with newly diagnosed untreated systemic lupus erythematosus. Ann Rheum Dis 63 12 (2004) 1677-1680
98. Silva C.A., Leal M.M., Leone C., et al. Gonadal function in adolescents and young women with juvenile systemic lupus erythematosus. Lupus 11 7 (2002) 419-425
99. Huong D.L., Amoura Z., Duhaut P., et al. Risk of ovarian failure and fertility after intravenous cyclophosphamide. A study in 84 patients. J Rheumatol 29 12 (2002) 2571-2576
100. Silva C.A., Hilario M.O., Febronio M.V., et al. Risk factors for amenorrhea in juvenile systemic lupus erythematosus (JSLE): a Brazilian multicentre cohort study. Lupus 16 7 (2007) 531-536
101. Brunner H.I., Bishnoi A., Barron A.C., et al. Disease outcomes and ovarian function of childhood-onset systemic lupus erythematosus. Lupus 15 4 (2006) 198-206
102. Silva C.A., and Brunner H.I. Gonadal functioning and preservation of reproductive fitness with juvenile systemic lupus erythematosus. Lupus 16 8 (2007) 593-599
103. Silva C.A., Hallak J., Pasqualotto F.F., et al. Gonadal function in male adolescents and young males with juvenile onset systemic lupus erythematosus. J Rheumatol 29 9 (2002) 2000-2005
104. Suehiro R.M., Borba E.F., Bonfa E., et al. Testicular Sertoli cell function in male systemic lupus erythematosus. Rheumatology (Oxford) 47 11 (2008) 1692-1697
105. Perilloux B.C., Shetty A.K., Leiva L.E., et al. Antinuclear antibody (ANA) and ANA profile tests in children with autoimmune disorders: a retrospective study. Clin Rheumatol 19 3 (2000) 200-203
106. Fox R.I. Sjogren's syndrome. Lancet 366 9482 (2005) 321-331
107. McGhee J.L., Kickingbird L.M., and Jarvis J.N. Clinical utility of antinuclear antibody tests in children. BMC Pediatr 4 (2004) 13
108. Breda L., Nozzi M., De Sanctis S., et al. Laboratory tests in the diagnosis and follow-up of pediatric rheumatic diseases: an update. Semin Arthritis Rheum (2009) [Epub ahead of print]
109. Esdaile J.M., Abrahamowicz M., Joseph L., et al. Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus. Why some tests fail. Arthritis Rheum 39 3 (1996) 370-378
110. Isenberg D.A., and Collins C. Detection of cross-reactive anti-DNA antibody idiotypes on renal tissue-bound immunoglobulins from lupus patients. J Clin Invest 76 1 (1985) 287-294
111. Reichlin M., Broyles T.F., Hubscher O., et al. Prevalence of autoantibodies to ribosomal P proteins in juvenile-onset systemic lupus erythematosus compared with the adult disease. Arthritis Rheum 42 1 (1999) 69-75
112. To C.H., and Petri M. Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus?. Arthritis Rheum 52 12 (2005) 4003-4010
113. Jurencak R., Fritzler M., Tyrrell P., et al. Autoantibodies in pediatric systemic lupus erythematosus: ethnic grouping, cluster analysis, and clinical correlations. J Rheumatol 36 2 (2009) 416-421
114. Campos L.M., Kiss M.H., Scheinberg M.A., et al. Antinucleosome antibodies in patients with juvenile systemic lupus erythematosus. Lupus 15 8 (2006) 496-500
115. Tikly M., Gould T., Wadee A.A., et al. Clinical and serological correlates of antinucleosome antibodies in South Africans with systemic lupus erythematosus. Clin Rheumatol 26 12 (2007) 2121-2125
116. Lettre G., and Rioux J.D. Autoimmune diseases: insights from genome-wide association studies. Hum Mol Genet 17 R2 (2008) R116-R121
117. Pickering M.C., and Walport M.J. Links between complement abnormalities and systemic lupus erythematosus. Rheumatology (Oxford) 39 2 (2000) 133-141
118. Kallel-Sellami M., Baili-Klila L., Zerzeri Y., et al. Hereditary complement deficiency and lupus: report of four Tunisian cases. Ann N Y Acad Sci 1108 (2007) 197-202
119. Yang Y., Lhotta K., Chung E.K., et al. Complete complement components C4A and C4B deficiencies in human kidney diseases and systemic lupus erythematosus. J Immunol 173 4 (2004) 2803-2814
120. Reveille J.D., Schrohenloher R.E., Acton R.T., et al. DNA analysis of HLA-DR and DQ genes in American blacks with systemic lupus erythematosus. Arthritis Rheum 32 10 (1989) 1243-1251
121. Barron K.S., Silverman E.D., Gonzales J., et al. Clinical, serologic, and immunogenetic studies in childhood-onset systemic lupus erythematosus. Arthritis Rheum 36 3 (1993) 348-354
122. Baca V., Catalan T., Villasis-Keever M., et al. Effect of low-dose cyclosporine A in the treatment of refractory proteinuria in childhood-onset lupus nephritis. Lupus 15 8 (2006) 490-495
123. Kyogoku C., Langefeld C.D., Ortmann W.A., et al. Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet 75 3 (2004) 504-507
124. Liao C.H., Yao T.C., Chung H.T., et al. Polymorphisms in the promoter region of RANTES and the regulatory region of monocyte chemoattractant protein-1 among Chinese children with systemic lupus erythematosus. J Rheumatol 31 10 (2004) 2062-2067
125. Jacob C.O., Reiff A., Armstrong D.L., et al. Identification of novel susceptibility genes in childhood-onset systemic lupus erythematosus using a uniquely designed candidate gene pathway platform. Arthritis Rheum 56 12 (2007) 4164-4173
126. Velazquez-Cruz R., Orozco L., Espinosa-Rosales F., et al. Association of PDCD1 polymorphisms with childhood-onset systemic lupus erythematosus. Eur J Hum Genet 15 3 (2007) 336-341
127. Brunner H.I., Klein-Gitelman M.S., Ying J., et al. Corticosteroid use in childhood-onset systemic lupus erythematosus-practice patterns at four pediatric rheumatology centers. Clin Exp Rheumatol 27 1 (2009) 155-162
128. Kumar S., Benseler S.M., Kirby-Allen M., et al. B-cell depletion for autoimmune thrombocytopenia and autoimmune hemolytic anemia in pediatric systemic lupus erythematosus. Pediatrics 123 1 (2009) e159-e163
129. Baca V., Lavalle C., Garcia R., et al. Favorable response to intravenous methylprednisolone and cyclophosphamide in children with severe neuropsychiatric Lupus. J Rheumatol 26 2 (1999) 432-439
130. Levy D.M., Massicotte M.P., Harvey E., et al. Thromboembolism in paediatric lupus patients. Lupus 12 10 (2003) 741-746
131. Harrison M.J., Ravdin L.D., and Lockshin M.D. Relationship between serum NR2a antibodies and cognitive dysfunction in systemic lupus erythematosus. Arthritis Rheum 54 8 (2006) 2515-2522
132. Bertsias G., and Boumpas D.T. Update on the management of lupus nephritis: let the treatment fit the patient. Nat Clin Pract Rheumatol 4 9 (2008) 464-472
133. Niaudet P. Treatment of lupus nephritis in children. Pediatr Nephrol 14 2 (2000) 158-166
134. Barbano G., Gusmano R., Damasio B., et al. Childhood-onset lupus nephritis: a single-center experience of pulse intravenous cyclophosphamide therapy. J Nephrol 15 2 (2002) 123-129
135. Lehman T.J., and Onel K. Intermittent intravenous cyclophosphamide arrests progression of the renal chronicity index in childhood systemic lupus erythematosus. J Pediatr 136 2 (2000) 243-247
136. Lehman T.J., Edelheit B.S., and Onel K.B. Combined intravenous methotrexate and cyclophosphamide for refractory childhood lupus nephritis. Ann Rheum Dis 63 3 (2004) 321-323
137. Falcini F., Capannini S., Martini G., et al. Mycophenolate mofetil for the treatment of juvenile onset SLE: a multicenter study. Lupus 18 2 (2009) 139-143
138. Hagelberg S., Lee Y., Bargman J., et al. Longterm followup of childhood lupus nephritis. J Rheumatol 29 12 (2002) 2635-2642
139. Lionaki S., Kapitsinou P.P., Iniotaki A., et al. Kidney transplantation in lupus patients: a case-control study from a single centre. Lupus 17 7 (2008) 670-675
140. Cochat P., Fargue S., Mestrallet G., et al. Disease recurrence in paediatric renal transplantation. Pediatr Nephrol 24 11 (2009) 2097-2108
141. Ghafari A., Etemadi J., and Ardalan M.R. Renal transplantation in patients with lupus nephritis: a single-center experience. Transplant Proc 40 1 (2008) 143-144
142. Moroni G., Tantardini F., Gallelli B., et al. The long-term prognosis of renal transplantation in patients with lupus nephritis. Am J Kidney Dis 45 5 (2005) 903-911
143. Drenkard C., Villa A.R., Garcia-Padilla C., et al. Remission of systematic lupus erythematosus. Medicine (Baltimore) 75 2 (1996) 88-98
144. Urowitz M.B., Feletar M., Bruce I.N., et al. Prolonged remission in systemic lupus erythematosus. J Rheumatol 32 8 (2005) 1467-1472
145. Cook C.D., Wedgwood R.J., Craig J.M., et al. Systemic lupus erythematosus. Description of 37 cases in children and a discussion of endocrine therapy in 32 of the cases. Pediatrics 26 (1960) 570-585
146. Glidden R.S., Mantzouranis E.C., and Borel Y. Systemic lupus erythematosus in childhood: clinical manifestations and improved survival in fifty-five patients. Clin Immunol Immunopathol 29 2 (1983) 196-210
147. Gonzalez B., Hernandez P., Olguin H., et al. Changes in the survival of patients with systemic lupus erythematosus in childhood: 30 years experience in Chile. Lupus 14 11 (2005) 918-923
148. Urowitz M.B., Gladman D.D., Tom B.D., et al. Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosus. J Rheumatol 35 11 (2008) 2152-2158
149. Chambers S.A., Allen E., Rahman A., et al. Damage and mortality in a group of British patients with systemic lupus erythematosus followed up for over 10 years. Rheumatology (Oxford) 48 6 (2009) 673-675
150. Doria A., Iaccarino L., Ghirardello A., et al. Long-term prognosis and causes of death in systemic lupus erythematosus. Am J Med 119 8 (2006) 700-706
151. Moss K.E., Ioannou Y., Sultan S.M., et al. Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades. Ann Rheum Dis 61 5 (2002) 409-413
152. Cervera R., Khamashta M.A., Font J., et al. Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) 78 3 (1999) 167-175
153. Bernatsky S., Boivin J.F., Joseph L., et al. Mortality in systemic lupus erythematosus. Arthritis Rheum 54 8 (2006) 2550-2557
154. Cervera R., Abarca-Costalago M., Abramovicz D., et al. Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project". Autoimmun Rev 5 3 (2006) 180-186
155. Bandeira M., Buratti S., Bartoli M., et al. Relationship between damage accrual, disease flares and cumulative drug therapies in juvenile-onset systemic lupus erythematosus. Lupus 15 8 (2006) 515-520
156. Fernandez M., Alarcon G.S., Apte M., et al. Systemic lupus erythematosus in a multiethnic US cohort: XLIII. The significance of thrombocytopenia as a prognostic factor. Arthritis Rheum 56 2 (2007) 614-621
157. Mok C.C., To C.H., Ho L.Y., et al. Incidence and mortality of systemic lupus erythematosus in a southern Chinese population, 2000-2006. J Rheumatol 35 10 (2008) 1978-1982
158. Koneru S., Shishov M., Ware A., et al. Effectively measuring adherence to medications for systemic lupus erythematosus in a clinical setting. Arthritis Rheum 57 6 (2007) 1000-1006
159. Ting V., Kudalkar D., Nelson S., et al. Use of cellular text messaging to improve visit adherence in adolescents with childhood-onset Systemic Lupus Erythematosus (cSLE). [abstract] (2009), American College of Rheumatology, Philadelphia
160. Al Dhanhani A.M., Gignac M.A., Su J., et al. Work disability in systemic lupus erythematosus. Arthritis Rheum 61 3 (2009) 378-385
161. Reiff A. Childhood quality of life in the changing landscape of pediatric rheumatology. J Pediatr (Rio J) 84 4 (2008) 285-288
162. Becker-Merok A., and Nossent H.C. Damage accumulation in systemic lupus erythematosus and its relation to disease activity and mortality. J Rheumatol 33 8 (2006) 1570-1577
163. Gutierrez-Suarez R., Ruperto N., Gastaldi R., et al. A proposal for a pediatric version of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index based on the analysis of 1,015 patients with juvenile-onset systemic lupus erythematosus. Arthritis Rheum 54 9 (2006) 2989-2996
164. Brunner H.I., Sherrard T.M., and Klein-Gitelman M.S. Cost of treatment of childhood-onset systemic lupus erythematosus. Arthritis Rheum 55 2 (2006) 184-188
165. Lau C.S., and Mak A. The socioeconomic burden of SLE. Nat Rev Rheumatol 5 7 (2009) 400-404
166. Sutcliffe N., Clarke A.E., Taylor R., et al. Total costs and predictors of costs in patients with systemic lupus erythematosus. Rheumatology (Oxford) 40 1 (2001) 37-47